| 2000xg/10min |
3000xg/7min |
3000xg/5min |
| Free haemoglobin, g/L |
41 |
/ |
0.05 (0.03) |
0.07 (0.04) |
0.07 (0.03) |
0.001 |
| Icterus index, index |
41 |
/ |
1 (0) |
1 (0) |
1 (0) |
0.99 |
| Lipemia index serum, index |
41 |
/ |
5 (4) |
6 (5) |
6 (5) |
0.99 |
| Anti-Müllerian hormone, pmol/L |
37 (4) |
4.4 |
25.7 (23.5) |
25.7 (23.5) |
25.7 (23.5) |
0.99 |
| Prealbumin, µmol/L |
41 |
5.7 |
4.8 (1.4) |
4.9 (1.1) |
4.8 (1.5) |
0.99 |
| Carcinoembryonic antigen, U/L |
38 (3) |
10.2 |
23.7 (16.1) |
23.7 (14.8) |
23.7 (14.8) |
0.99 |
| Alpha Fetoprotein, U/L |
38 (3) |
7.4 |
19.9 (13.1) |
19.9 (14.5) |
19.9 (12.9) |
0.99 |
| Cytokeratin fragment 21-1, µg/L |
41 |
6.1 |
1.2 (0.7) |
1.2 (0.8) |
1.2 (0.7) |
0.99 |
| Cancer-Antigen 125, U/L |
41 |
5.7 |
120 (60) |
120 (80) |
120 (70) |
0.99 |
| Cancer-Antigen19-9, U/L |
41 |
6.2 |
70 (150) |
70 (150) |
60 (150) |
0.99 |
| Cancer-Antigen 15-3, U/L |
41 |
6.4 |
170 (110) |
170 (100) |
170 (110) |
0.99 |
| S100 protein, µg/L |
41 |
7.2 |
0.05 (0.02) |
0.05 (0.02) |
0.05 (0.02) |
0.99 |
| Neuron specific enolase, µg/L |
41 |
6.2 |
11 (3) |
12 (3) |
12 (3) |
0.71 |
| Cancer-Antigen 72-4, U/L |
41 |
6.5 |
13 (37) |
13 (36) |
13 (37) |
0.99 |
| Cystatin C, nmol/L |
41 |
2.9 |
62.9 (11.2) |
62.9 (12) |
62.9 (12.7) |
0.99 |
| Cystatin C estimated glomerular filtration rate, mL/min/1.73m2
|
41 |
/ |
97 (19) |
99 (19) |
98 (20) |
0.99 |
| Soluble fms-like tyrosine kinase-1, pg/mL |
41 |
16.0 |
89.4 (11.7) |
89.9 (11) |
88.8 (13.1) |
0.99 |
| Placental growth factor, pg/mL |
41 |
16.8 |
14.89 (4.5) |
14.64 (4.2) |
14.95 (4.2) |
0.99 |
| sFlt1/PlGF Ratio, ratio |
41 |
/ |
6.29 (1.6) |
6.4 (1.6) |
6.4 (1.6) |
0.99 |
| Data are presented as median and interquartile range. P < 0.05 was considered statistically significant. *Amount of individual samples used for calculation. In those parameters where this value is less than 41, some of the samples had measured values below the measuring range of the respective assay. The number of excluded samples, where applicable, are shown in parentheses. †All assays were performed on a COBAS 8000 instrument (Roche Diagnostics) using only proprietary reagents. CVs of day-to-day QC control values of the respective parameter. CV – coefficient of variation. |
